Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01708993
Title Reolysin in Patients With Previously Treated Advanced or Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group|Oncolytics Biotech
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Pemetrexed Disodium

Pelareorep + Pemetrexed Disodium

Docetaxel + Pelareorep

Age Groups: adult
Covered Countries CAN


No variant requirements are available.